Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Pretax income is the income that a company earns before paying income taxes. Embla Medical hf's pretax income for the
three
months ended in Jun. 2026 was $38.3 Mil.
Its pretax income for the trailing twelve months (TTM) ended in Jun. 2026 was $121.9 Mil.
Embla Medical hf's pretax margin was 14.82%.
During the past 13 years, Embla Medical hf's highest Pretax Margin was 15.81%. The lowest was 2.02%. And the median was 11.84%.
Embla Medical hf (OTCPK:OSSFF) Pre-Tax Income Explanation
Embla Medical hf's Pretax Margin for the quarter that ended in Jun. 2026 is calculated as
During the past 13 years, Embla Medical hf's highest Pretax Margin was 15.81%. The lowest was 2.02%. And the median was 11.84%.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Embla Medical hf Pre-Tax Income Related Terms
Embla Medical hf Pre-Tax Income Historical Data
* Premium members only.
The historical data trend for Embla Medical hf's Pre-Tax Income can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Devices subindustry, Embla Medical hf's Pre-Tax Income, along with its competitors' market caps and Pre-Tax Income data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Embla Medical hf Pre-Tax Income vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Embla Medical hf's Pre-Tax Income distribution charts can be found below:
* The bar in red indicates where Embla Medical hf's Pre-Tax Income falls into.
Pre-Tax Income for the trailing twelve months (TTM) ended in Jun. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $121.9 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Embla Medical hf (OSSFF) has a Pre-Tax Income of $121.9 Mil as of Jun. 2026. Pre-Tax Income is the total earnings before taxes but after all operating and interest expenses. View historical data on Embla Medical hf and its competitors.
Is Embla Medical hf's Pre-Tax Income too high?
Embla Medical hf's current Pre-Tax Income is $121.9 Mil. Overall, Embla Medical hf has a GF Score™ of 93/100, reflecting its overall financial health beyond just this single metric.
How does Embla Medical hf's Pre-Tax Income compare to ABT and SYK?
Embla Medical hf's Pre-Tax Income of $121.9 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Pre-Tax Income for a Medical Devices & Instruments company?
A good Pre-Tax Income depends on the Medical Devices & Instruments industry context. However, Pre-Tax Income should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Pre-Tax Income mean?
A high Pre-Tax Income can signal that a stock is expensive relative to its fundamentals. Pre-Tax Income is the total earnings before taxes but after all operating and interest expenses. View historical data on Embla Medical hf and its competitors. Embla Medical hf's current Pre-Tax Income is $121.9 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Embla Medical hf stock overvalued right now?
Embla Medical hf (OSSFF) has a current Pre-Tax Income of $121.9 Mil. The stock's GF Value™ is $5.03, compared to a current price of $4.15 — trading 17.5% below its estimated fair value. The current Pre-Tax Income is $121.9 Mil. Embla Medical hf's overall GF Score™ is 93/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Pre-Tax Income calculated?
Pre-Tax Income is calculated from a company's financial statements. For Embla Medical hf (OSSFF), the current Pre-Tax Income is $121.9 Mil as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Embla Medical hf (OSSFF) Overvalued in 2026?
Based on GuruFocus' analysis, Embla Medical hf stock appears to be undervalued.
The current stock price of $4.15 is trading 17.5% below its estimated GF Value™ of $5.03.
Key valuation signals for OSSFF:
Pre-Tax Income: $121.9 Mil
GF Value™: $5.03 vs. price of $4.15 (17.5% below fair value)
No single metric tells the full story. See the OSSFF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Embla Medical hf operates as an orthopedic products company specializing in the design, development, manufacturing and sales of prosthetics and bracing & supports products. The company also provides patient care through a network of Orthotic and Prosthetic (O&P) facilities. It sells its products in multiple countries, with Europe and North America representing its principal markets. The company operates within three business segments: Prosthetics & Neuro Orthotics, Bracing & Supports and Patient Care. The majority of the company's revenue is derived from the Prosthetics & Neuro Orthotics, which includes products designed for users with varying mobility needs, ranging from lower-activity applications to solutions intended for more active use.
93GF Score
Get the complete analysis for OSSFF
Pre-Tax Income is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
OSSFF has been successfully added to your 
